Max Robotics — Global Service Robot Directory + US Certification

About

Debbie Dong is a leading figure in functional genomics and antibody engineering, best known for her pioneering work in developing high-throughput platforms for recombinant antibody generation. Her most cited paper, "A High Through-put Platform for Recombinant Antibodies to Folded Proteins" (2015, 120 citations), revolutionized the production of renewable, sequence-defined antibodies by establishing an industrialized pipeline for 346 transcription factors. This work addressed a critical bottleneck in biomedical research—the reliance on non-renewable commercial antibodies—by enabling scalable validation and permanent resource creation. Dong’s contributions have had a profound impact on proteomics and cellular biology, providing researchers with reliable tools to study protein function at scale. Her platform is widely recognized as a foundational advance in antibody engineering, bridging the gap between genomics and proteomics. Beyond this landmark study, Dong has been instrumental in advancing recombinant antibody technologies for folded proteins, earning her a reputation as a key innovator in the field. Her work continues to empower large-scale protein characterization and therapeutic antibody development, making her a vital resource for students and researchers seeking robust, reproducible reagents.